{"name":"Innocrin Pharmaceutical","slug":"innocrin-pharmaceutical","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE9zb2VTVmZQaG93TXFrNjhrTnUyeG40aG9IRENHWnlQekR4TEVOcVFubl82NWxoNWNkSlBCblhXV2loS0RlZWdzMzUzWlg4UjhHRmZwWHREa0N4SmR4cjJ6YzBkemNFQ3J5N2JMUA?oc=5","date":"2025-09-04","type":"pipeline","source":"Neuroscience News","summary":"Dietary Intervention Could Slow Deadly Brain Cancer Growth - Neuroscience News","headline":"Dietary Intervention Could Slow Deadly Brain Cancer Growth","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxNcndPcW54RHBmUllUVzV5VGQ3SS13TzZYazJ1eXNpWUxRMkM2TDNTd2xrUUkwb3dfdFNRT0Z6dllUZDlnbFZmWFBnN2lNaVctdndYb09UQ3ZDcVlabHB4dHZQUjcxc20yTDJfNFhoeGNMQ01zaFN3ekpNMks3YmMzSHlEeGthOGhSYkRWMUtDV1Vja1J0Z3J1QmloM0EzSFV4MXEzUFY1ZmJvZUk?oc=5","date":"2015-04-16","type":"pipeline","source":"The Business Journals","summary":"Fred Eshelman makes another investment: experimental cancer treatment - The Business Journals","headline":"Fred Eshelman makes another investment: experimental cancer treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxQbnZFa25tdUFiS3JqUEFNWENQdHF5WkdzeXlJcWNzY2xZYm5HTkhfenlrMjhhSU5TWkxjalE2N2ZNQ1JfcDI5dVNPYWxfYjdvQk1RV05VeU1FQy16YXpZeWhPWHdqbnF1UmpHdU1BUGtYaUNla3VoT2t0MnFPR2FCWmNqZEh0Vkg5bHFuMXZ6YW5qUkpYNDlHYW95ZWx0SUZ0U2Y5cjZORkRIUGdFUllzU1BocHctaGUzalNSUGxDTVhhYjBGcUhWQWRjLU84d1E?oc=5","date":"2014-10-22","type":"pipeline","source":"BioSpace","summary":"Viamet Pharmaceuticals Withdraws $75 Million IPO, Spins Off Cancer Program To Form Innocrin Pharmaceuticals - BioSpace","headline":"Viamet Pharmaceuticals Withdraws $75 Million IPO, Spins Off Cancer Program To Form Innocrin Pharmaceuticals","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}